In parallel, miR-21 overexpression in human cholangiocarcinoma inhibits PDCD418, while promoting migration and invasion through PDCD4 and activator protein 1 (AP-1) in HCC19. The gene discussed is JUN; the disease is cholangiocarcinoma.